产品优势：
（1）自主化、国产化的原研体系；供货稳定，高性价比；
（2）支持临床级/药品级细胞培养，培养的iPSC细胞通过了中国食品药品检定研究院质量复核；iPSC来源功能药物通过了IND默示许可。
产品规格
| 名称 | 规格 | 货号 | 存储条件 |
VTN包被蛋白 | 1mg (2mL) | RP01002 | -20°C~-80℃ |
细胞形态与生长情况
VTN包被蛋白连续培养的hiPSC（P20）细胞形态图示，使用hiPSC/hESC 培养基-ncEpic培养。
A、B、C分别为培养第1、2、4天时，显微镜下hiPSC的形态图示，标尺：200μm。
文献引用
Base editing-mediated splicing correction therapy for spinal muscular atrophy
2020. Xiang Lin, et al.. Cell Research(IF 46.297).
Embryonic Stem Cell Derived Small Extracellular Vesicles Modulate Regulatory T Cells to Protect against Ischemic Stroke
2020. Yuguo Xia, et al.. ACS Nano(IF 18.027).
Inducible Pluripotent Stem Cel-Derived Small Extracellular Veicles Rejuvenate Senescent Blood-Brain Barier to Protect against schemic Stroke in Aged..
2022. Qing Li, et al. ACS Nano(IF 18.0280).
ESC‐sEVs Rejuvenate Senescent Hippocampal NSCs by Activating Lysosomes to Improve Cognitive Dysfunction in Vascular Dementia
2020. Guowen Hu, et al.. Advanced Science(IF 17.521).
Human ESC-sEVs alleviate age-related bone loss by rejuvenating senescent bone marrow-derived mesenchymal stem cels
2020. Liangzhi Gong, et al. Journal of Extracellular Vesicles(lF 17.3378)
更多文献引用，请拨打021-61283010详细咨询
